2024
Aryl Hydrocarbon Receptor Modulation at the Nexus of Insulin Resistance and Chemoresistance in Triple-Negative Breast CancerJournal of Pharmacology and Experimental Therapeutics, Cancer, Hypoxia, and Metabolism
Active, last published 2026
In cancer, hypoxia, and metabolism
Wessam
Elsaied
“Research focused on Cancer, Hypoxia, and Metabolism and adjacent fields.”
Claim Your Profile0
H-index
0
Citations
Wessam has not officially claimed their profile. If you are Wessam, claim it free.
Claim Your Profile01 · About the work
What I study
essam Elsaied is a researcher working on Cancer, Hypoxia, and Metabolism. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Wessam's work has been cited 0 times across 1 active year. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
05 · Research focus
Topics
Cancer, Hypoxia, and Metabolism×1Cancer, Stress, Anesthesia, and Immune Response×1Eicosanoids and Hypertension Pharmacology×1
06 · Where I am
Affiliations
CurrentlyBritish University in Egypt, Egypt
07 · Selected work
Recent publications
Are you Wessam?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
No commitment required